King's Health Partners Teams with IDBS on Personalized Cancer Therapy Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IDBS said today it will be providing its Oncology Research Information System translational medicine platform for the Integrated Cancer Centre at King's Health Partners.

The deal, the UK data management and analytics solutions firm said, is the first step in a five-year relationship that may eventually include all disease areas including cancer disorders and cardiovascular diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.